In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9

Shuai Zhen(Maternal and Child Health Care Hospital of Bao'an), Hua Ling(Beijing Radiation Center), Yōichirō Takahashi(Kyoto University), Shunichi Narita(Kyoto University), Yunhui Liu(Beijing Radiation Center), Yan Li(Baoji City Central Hospital)

Biochemical and Biophysical Research Communications

July 17, 2014

10.1016/j.bbrc.2014.07.014

Cited by 215

Abstract

Related Papers

RNA-Guided Human Genome Engineering via Cas9

Prashant Mali, Luhan Yang, Kevin M. Esvelt et al.|Science|2013|9.4k

The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product

Nicholas J. Dyson, Peter M. Howley, Karl Münger et al.|Science|1989|3.1k

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Bruce A. Werness, Arnold J. Levine, Peter M. Howley|Science|1990|2.6k

CRISPR/Cas, the Immune System of Bacteria and Archaea

Philippe Horvath, Rodolphe Barrangou|Science|2010|2.5k

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

Elisabeth Schwarz, U.K. Freese, Lutz Gissmann et al.|Nature|1985|1.5k